rs3736638

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.1971+123C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0506 in 797,364 control chromosomes in the GnomAD database, including 4,062 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.084 ( 1266 hom., cov: 32)
Exomes 𝑓: 0.043 ( 2796 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.132

Publications

11 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 7-94417954-C-A is Benign according to our data. Variant chr7-94417954-C-A is described in ClinVar as Benign. ClinVar VariationId is 678062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.36 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.1971+123C>A intron_variant Intron 32 of 51 ENST00000297268.11 NP_000080.2 P08123A0A0S2Z3H5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.1971+123C>A intron_variant Intron 32 of 51 1 NM_000089.4 ENSP00000297268.6 P08123
COL1A2ENST00000461525.5 linkn.60+123C>A intron_variant Intron 1 of 6 1
COL1A2ENST00000473573.5 linkn.308+123C>A intron_variant Intron 4 of 10 2
COL1A2ENST00000497316.5 linkn.368+123C>A intron_variant Intron 1 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.0840
AC:
12759
AN:
151908
Hom.:
1257
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0655
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.0683
Gnomad FIN
AF:
0.0323
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0102
Gnomad OTH
AF:
0.0758
GnomAD4 exome
AF:
0.0427
AC:
27569
AN:
645338
Hom.:
2796
AF XY:
0.0416
AC XY:
14256
AN XY:
342792
show subpopulations
African (AFR)
AF:
0.196
AC:
3355
AN:
17132
American (AMR)
AF:
0.0685
AC:
2330
AN:
34038
Ashkenazi Jewish (ASJ)
AF:
0.0143
AC:
284
AN:
19892
East Asian (EAS)
AF:
0.356
AC:
11446
AN:
32124
South Asian (SAS)
AF:
0.0536
AC:
3356
AN:
62666
European-Finnish (FIN)
AF:
0.0314
AC:
1270
AN:
40420
Middle Eastern (MID)
AF:
0.0162
AC:
43
AN:
2652
European-Non Finnish (NFE)
AF:
0.00952
AC:
3837
AN:
403144
Other (OTH)
AF:
0.0495
AC:
1648
AN:
33270
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
1019
2037
3056
4074
5093
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0842
AC:
12800
AN:
152026
Hom.:
1266
Cov.:
32
AF XY:
0.0853
AC XY:
6339
AN XY:
74320
show subpopulations
African (AFR)
AF:
0.200
AC:
8289
AN:
41428
American (AMR)
AF:
0.0656
AC:
1002
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0138
AC:
48
AN:
3472
East Asian (EAS)
AF:
0.374
AC:
1925
AN:
5142
South Asian (SAS)
AF:
0.0680
AC:
326
AN:
4796
European-Finnish (FIN)
AF:
0.0323
AC:
343
AN:
10616
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0102
AC:
692
AN:
67980
Other (OTH)
AF:
0.0802
AC:
169
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
517
1034
1551
2068
2585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0362
Hom.:
1591
Bravo
AF:
0.0934
Asia WGS
AF:
0.238
AC:
828
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.5
DANN
Benign
0.51
PhyloP100
-0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3736638; hg19: chr7-94047266; COSMIC: COSV51969149; COSMIC: COSV51969149; API